U-BPTH

Q:BPTH - BIO-PATH HOLDINGS INC - https://www.biopathholdings.com

00:17:50 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BPTH - Q	not subscribed					0.05909	-0.00091	-1.5	9.8	0	11	0.058775 0.05909 0.0572	0.2316 0.0501	15:48:26	Jun 09	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market: OTC Markets -- Tier: OTC Pink Limited -- Status: Active

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 11

More trades...

Time ET	Ex	Price	Change	Volume
15:48:26	Q	0.05909	-0.00091	100
14:48:59	Q	0.0572	-0.0028	1
14:01:39	Q	0.0572	-0.0028	1
14:01:07	Q	0.0588	-0.0012	1
14:01:07	Q	0.0572	-0.0028	1
12:45:46	Q	0.058775	-0.001225	1
11:26:17	Q	0.0572	-0.0028	3,723
11:26:08	Q	0.0572	-0.0028	4,486
10:07:57	Q	0.0572	-0.0028	1
10:01:23	Q	0.058775	-0.001225	1,500

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-06-09 07:00	U:BPTH	News Release200	Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
2025-06-04 16:36	U:BPTH	News Release200	Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25
2025-06-03 07:00	U:BPTH	News Release200	Bio-Path Holdings Provides Clinical and Operational Update
2025-05-22 16:30	U:BPTH	News Release200	Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
2025-05-01 07:00	U:BPTH	News Release200	Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
2025-03-28 07:00	U:BPTH	News Release200	Bio-Path Holdings Reports Full Year 2024 Financial Results
2025-03-18 07:00	U:BPTH	News Release200	Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
2025-02-13 16:02	U:BPTH	News Release200	Bio-Path Holdings Expands Global Patent Portfolio
2025-02-13 08:00	U:BPTH	News Release200	Bio-Path Holdings Provides Key Clinical Updates
2025-02-12 16:01	U:BPTH	News Release200	Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid Leukemia

Date ET

Symbol

Type

Headline

2025-06-09 07:00

U:BPTH

News Release

Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum

2025-06-04 16:36

U:BPTH

News Release

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25